Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiko Okikawa

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2017
Successful management of recurrent bleeding with tocilizumab in an acquired hemophilia A patient with rheumatoid arthritisAkiko Hashimoto, Toshiro Takafuta, Miki Kido, et al.
American Journal of Ophthalmology Case Reports|July 7, 2018
A case of primary extranodal natural killer/T-cell lymphoma in the orbit and intraocular tissues with cerebrospinal fluid involvementArisa Okada, Yosuke Harada, Tomoko Inoue, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[Angioimmunoblastic T-cell lymphoma complicated with EBV-associated B-cell lymphoma]Shoso Munemasa, Akira Sakai, Naomi Sasaki, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2011
Good's syndrome-associated pure red cell aplasia with myelodysplastic syndromeHideaki Nitta, Yuka Harada, Yoshiko Okikawa, et al.
Blood|September 24, 2010
Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemiaJun Imagawa, Yuka Harada, Takeshi Shimomura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 30, 2003
[Single-agent thalidomide for advanced and refractory multiple myeloma]Yoshiko Okikawa, Yasuo Takimoto, Masaaki Noda, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2018
The Progression of Esophageal Mucosa-associated Lymphoid Tissue Lymphoma after Helicobacter pylori Eradication Therapy: A Case Report and Discussion of Therapeutic OptionsYukari Takeuchi, Koji Miyahara, Toshiaki Morito, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2026
True Hemothorax as the Initial Presentation of Prostate Adenocarcinoma with Pleural Metastasis: A Case ReportToru Kuratomi, Shun Takao, Maho Iwasaki, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2025
A Rare Case of Occult Small-cell Lung Cancer with Initial Manifestations of Brain MetastasesRen Seike, Shun Takao, Maho Iwasaki, et al.
International Journal of Oncology|June 26, 2008
Osteoprogenitor differentiation is not affected by immunomodulatory thalidomide analogs but is promoted by low bortezomib concentration, while both agents suppress osteoclast differentiationShoso Munemasa, Akira Sakai, Yoshiaki Kuroda, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2017
Successful management of recurrent bleeding with tocilizumab in an acquired hemophilia A patient with rheumatoid arthritisAkiko Hashimoto, Toshiro Takafuta, Miki Kido, et al.
American Journal of Ophthalmology Case Reports|July 7, 2018
A case of primary extranodal natural killer/T-cell lymphoma in the orbit and intraocular tissues with cerebrospinal fluid involvementArisa Okada, Yosuke Harada, Tomoko Inoue, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[Angioimmunoblastic T-cell lymphoma complicated with EBV-associated B-cell lymphoma]Shoso Munemasa, Akira Sakai, Naomi Sasaki, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2011
Good's syndrome-associated pure red cell aplasia with myelodysplastic syndromeHideaki Nitta, Yuka Harada, Yoshiko Okikawa, et al.
Blood|September 24, 2010
Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemiaJun Imagawa, Yuka Harada, Takeshi Shimomura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 30, 2003
[Single-agent thalidomide for advanced and refractory multiple myeloma]Yoshiko Okikawa, Yasuo Takimoto, Masaaki Noda, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2018
The Progression of Esophageal Mucosa-associated Lymphoid Tissue Lymphoma after Helicobacter pylori Eradication Therapy: A Case Report and Discussion of Therapeutic OptionsYukari Takeuchi, Koji Miyahara, Toshiaki Morito, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2026
True Hemothorax as the Initial Presentation of Prostate Adenocarcinoma with Pleural Metastasis: A Case ReportToru Kuratomi, Shun Takao, Maho Iwasaki, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2025
A Rare Case of Occult Small-cell Lung Cancer with Initial Manifestations of Brain MetastasesRen Seike, Shun Takao, Maho Iwasaki, et al.
International Journal of Oncology|June 26, 2008
Osteoprogenitor differentiation is not affected by immunomodulatory thalidomide analogs but is promoted by low bortezomib concentration, while both agents suppress osteoclast differentiationShoso Munemasa, Akira Sakai, Yoshiaki Kuroda, et al.
Pageof 3